|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquisition
|
none reported
|
|
gptkbp:business_model
|
biopharmaceutical development
|
|
gptkbp:can_lead_to
|
gptkb:Selinexor
|
|
gptkbp:ceo
|
gptkb:Michael_Kauffman
|
|
gptkbp:clinical_trial
|
various
global
multiple
ongoing
analyzed
innovative
published
Phase 1, Phase 2, Phase 3
late-stage
|
|
gptkbp:collaborations
|
ongoing
academic institutions
various studies
|
|
gptkbp:community_engagement
|
philanthropic initiatives
|
|
gptkbp:drug_candidates
|
in development
|
|
gptkbp:employees
|
over 100
|
|
gptkbp:financial_performance
|
reported quarterly
|
|
gptkbp:financial_reports
|
quarterly and annual
|
|
gptkbp:focus
|
gptkb:cancer_treatment
|
|
gptkbp:founded
|
gptkb:2010
|
|
gptkbp:founder
|
gptkb:Michael_Kauffman
|
|
gptkbp:has_advisory_board
|
established
|
|
gptkbp:headquarters
|
gptkb:Newton,_Massachusetts
|
|
gptkbp:healthcare
|
gptkb:2019
FDA approved drugs
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Karyopharm Therapeutics
|
|
gptkbp:instruction_set
|
multiple candidates
|
|
gptkbp:invention
|
multiple granted
|
|
gptkbp:investment
|
gptkb:venture_capital
active
frequent
institutional and retail
regularly conducted
|
|
gptkbp:investment_focus
|
oncology
|
|
gptkbp:market_cap
|
varies
|
|
gptkbp:market_launch
|
planned
|
|
gptkbp:marketing_strategy
|
focused on oncology
|
|
gptkbp:notable_products
|
gptkb:Selinexor
|
|
gptkbp:partnership
|
research organizations
|
|
gptkbp:partnerships
|
various pharmaceutical companies
formed
|
|
gptkbp:publications
|
numerous
|
|
gptkbp:regulatory_compliance
|
ongoing
managed internally
|
|
gptkbp:research
|
conducted
|
|
gptkbp:research_and_development
|
focused on nuclear transport
|
|
gptkbp:research_areas
|
hematologic malignancies
nuclear export inhibition
|
|
gptkbp:research_focus
|
nuclear transport mechanisms
|
|
gptkbp:stock_symbol
|
KPTI
|
|
gptkbp:strategic_goals
|
expand product pipeline
|
|
gptkbp:team
|
experienced professionals
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:website
|
www.karyopharm.com
|
|
gptkbp:bfsParent
|
gptkb:Ariad_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
5
|